Managing hyponatremia in lung cancer: latest evidence and …
Most of the available data focus on thoracic tumors, especially small-cell lung cancer (SCLC), where hyponatremia is frequently related to the syndrome of inappropriate secretion of …
SIADH and Small-Cell Lung Cancer: What's the Link? - WebMD
Jul 24, 2022 · Syndrome of Inappropriate Anti-Diuretic Hormone secretion, or SIADH, is a known complication of small-cell lung cancer (SCLC). SIADH makes your body produce too much of …
SIADH (Syndrome of Inappropriate Antidiuretic Hormone …
Aug 3, 2022 · Certain cancers: Certain tumors can produce their own ADH, leading to excess ADH in your body and SIADH. Small cell lung cancer (SCLC) is the most common tumor …
Malignancy associated SIADH: Characterization and clinical …
May 20, 2016 · Background: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the most common etiology of hyponatremia in cancer patients. SIADH in this population might …
Diagnosis and Management of Hyponatremia in Cancer Patients
Hyponatremia in the cancer patient is usually caused by the syndrome of inappropriate antidiuretic hormone (SIADH), which develops more frequently with SCLC than with other malignancies.
Syndrome of inappropriate secretion of anti-diuretic hormone (SIADH…
The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is one of the paraneoplastic syndrome which has a well-established linkage to small cell lung cancer. It …
SIADH and Small Cell Lung Cancer: What’s the Connection?
Apr 24, 2024 · Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common complication of small cell lung cancer (SCLC). Between 10 percent and 45 percent of people …
Paraneoplastic Syndromes in Lung Cancer: SIADH
Dec 22, 2016 · One of the most common paraneoplastic syndromes associated with lung cancer is the syndrome of inappropriate antidiuretic hormone (SIADH) secretion. Up to 16% of …
A patient with a small-cell lung cancer (SCLC) developed an asymptomatic hyponatremia, with all features o thfe syndrome of inappropriate antidiuretic hormone secretion (SIADH), two days …
Hyponatraemia—SIADH in lung cancer diagnostic and
Oct 1, 2015 · Hyponatraemia is a common finding in SCLC (25%) which can be assigned to a paraneoplastic syndrome termed syndrome of inappropriate ADH secretion (SIADH) in 60% of …
Hyponatraemia--SIADH in lung cancer diagnostic and treatment ... - PubMed
Hyponatraemia is a common finding in SCLC (25%) which can be assigned to a paraneoplastic syndrome termed syndrome of inappropriate ADH secretion (SIADH) in 60% of cases. …
Hyponatremia (Low Sodium Levels) and Lung Cancer: Causes …
Jul 1, 2024 · There are two main types of lung cancer — non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Hyponatremia is much more common in those with SCLC. …
P30.02 Assessing SIADH (Syndrome of Inapproriate Antidiuretic Hormone ...
SIADH represents the most common cause of hyponatremia (serum sodium concentration < 135 mEq/l) in cancer patients with an incidence up to 44% in patients with lung cancer. If primary …
A QUEST TO FIND THE MISSING SALT: SIADH IN THE SETTING OF …
Development of SIADH in non-small cell lung cancer (NSCLC) is not well documented. We describe a case of a patient who developed SIADH with diagnosed Stage IV lung …
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH …
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is a condition characterized by hypotonic and euvolemic hyponatremia along with urinary hyperosmolarity, …
SIADH and Lung Cancer: Connection and Symptoms Guide
SIADH is a major issue for many with lung cancer, affecting more than just electrolyte balance. As a paraneoplastic syndrome, it can change treatment and care plans significantly. This guide …
- [PDF]
Lung Cancer - CHEST
Development of SIADH in non-small cell lung cancer (NSCLC) is not well documented. We describe a case of a patient who developed SIADH with diagnosed Stage IV lung …
What to know about non-small cell lung cancer and hyponatremia
Aug 31, 2021 · Non-small cell lung cancer (NSCLC) causes cancerous cells to grow within lung tissues. Some people with NSCLC may experience low sodium levels, known as …
Syndrome of Inappropriate Antidiuretic Hormone (SIADH) in
Jan 13, 2025 · The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a complex and often underdiagnosed disorder characterized by impaired water homeostasis, …
Small-cell carcinoma - Wikipedia
Small-cell carcinoma is a type of highly malignant cancer that most commonly arises within the lung, [1] although it can occasionally arise in other body sites, such as the cervix, [2] prostate, …
A rapid and efficient way to manage hyponatremia in patients with SIADH …
Hyponatremia based on syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH) is observed in up to 15% of patients with small cell lung cancer (SCLC). The electrolyte …
Rearranged during transfection (RET) lung cancer - ScienceDirect
Lung cancer is the most frequently diagnosed cancer in 2022 comprising nearly 2.5 million cases and accounting for 12.4 % of all cancer diagnoses globally and over 1.8 million ... including …
Bob Uecker Dies at 90 from Small-Cell Lung Cancer - OncoDaily
Jan 16, 2025 · Key Statistics and Insights of Small Cell Lung Cancer. Small cell lung cancer (SCLC) accounts for 10-15% of all lung cancer cases, with 90% of patients being smokers or …
Immunotherapy for advanced-stage squamous cell lung cancer
Jan 6, 2025 · Immune-checkpoint inhibitors (ICIs) have transformed the treatment paradigm for advanced-stage squamous non-small-cell lung cancer (LUSC), a histological subtype …
Syndrome of inappropriate anti-diuretic hormone in non-small cell lung …
However, the syndrome of inappropriate anti-diuretic hormone secretion (SIADH) is rare in non-small cell lung cancer (NSCLC). We are reporting the case of a 58-year-old female presenting …
PRDX2 induces tumor immune evasion by modulating the HDAC3 …
6 days ago · This study aims to investigate the impact of PRDX2, which is highly expressed in lung adenocarcinoma, on T cells in the tumor immune microenvironment, and its immune …
- Some results have been removed